Embracing a quality mindset for successful end-to-end CDMO operations
A quality mindset is the foundation for CDMOs to bring innovative solutions in time for clients. Working with people ingrained in such a mindset can support clients to appropriately leverage cutting-edge technologies, advanced platforms and facilities, and scalable bioreactors to complete true end-to-end drug development and manufacturing.
Three of our industry veterans - Daniel Buckley of drug development, Soyeon Ahn of drug substance manufacturing, and Sungjin Park of drug product manufacturing - provide their real-life thought leadership on how working with a quality-minded CDMO leads to agile problem-solving of biopharmaceutical challenges.
Read this European Biopharmaceutical Review article to learn how CDMOs can cultivate a culture of quality.
Read more (page 13)
A quality mindset is the foundation for CDMOs to bring innovative solutions in time for clients. Working with people ingrained in such a mindset can support clients to appropriately leverage cutting-edge technologies, advanced platforms and facilities, and scalable bioreactors to complete true end-to-end drug development and manufacturing.
Three of our industry veterans - Daniel Buckley of drug development, Soyeon Ahn of drug substance manufacturing, and Sungjin Park of drug product manufacturing - provide their real-life thought leadership on how working with a quality-minded CDMO leads to agile problem-solving of biopharmaceutical challenges.
Read this European Biopharmaceutical Review article to learn how CDMOs can cultivate a culture of quality.
Read more (page 13)
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article